黛力新联合穴位敷贴治疗功能性消化不良上腹疼痛综合征的临床研究  

Clinical Study on the Treatment of Functional Dyspepsia Epigastric Pain Syndrome by Deanxit Combined with Acupoint Application

作　　者：凌家生[1] 宋斌[1] 戚红亮 黄献华[1] 

机构地区：[1]惠州市中医医院,广东惠州516001

出　　处：《中医药导报》2015年第17期53-55,共3页Guiding Journal of Traditional Chinese Medicine and Pharmacy

基　　金：惠州市科技局课题基金项目(2012B040011003);项目名称:药穴结合联合治疗功能性消化不良上腹疼痛综合征的临床研究

摘　　要：目的:观察黛力新口服联合曼吉磁贴穴位敷贴治疗功能性消化不良上腹疼痛综合征(EPS)的临床疗效。方法:将136例EPS患者采取随机分为两组。治疗组68例予黛力新联合曼吉磁贴敷贴、按压中脘及双侧内关、足三里穴;对照组68例予奥美拉唑胶囊及伊托必利口服。治疗4周后,观察两组治疗前后临床症状变化,评估疗效。结果:治疗组总有效率为88.2%,对照组为70.6%,两组比较,差异有统计学意义(P<0.05)。治疗组在降低患者腹痛、饱胀单项症状积分等方面优于对照组,差异有统计学意义(P<0.05)。在改善精神状态方面,通过抑郁自评量表(SDS)和焦虑自评量表(SAS)2项表格评分比较,治疗组优于对照组,差异均有统计学意义(P<0.05)。结论:黛力新口服联合曼吉磁贴穴位敷贴治疗功能性消化不良上腹疼痛综合征效果显著。Objective： To observe the therapeutic effect of Deanxit combined with point application on treating epi-gastric pain syndrome （EPS）. Methods： The136 EPS patients were randomly divided into two groups. The 68 cases in treatment group were given Deanxit, point application of ＂Zhongwan （RN12） Neiguan （PC6）＂ and ＂Zusanli （ST36）＂. The 68 cases in control group were given Losec and Itopride. The clinical efficacy was analyzed 4 weeks later, and the change of the symptom was observed. Results： The total efficiency was 88.2% in treatment group and 70.6% in control group; comparing the 2 groups, the difference was significant（P〈0.05）. The symptoms of abdominal pain and postprandial fullness were more sufficiently improved in treatment group （P〈0.05）. By self rating Depression Scale （SDS） and self rating Anxiety Scale （SAS） scores comparing, the treatment group was better than that of the control group, with significant difference （P〈0.05）. Conclusion： Deanxit combined with oral Manji magnetic plaster acupoint application can provide obvious effect for functional dyspepsia epigastric pain syndrome.

关 键 词：黛力新 曼吉磁贴 功能性消化不良 上腹疼痛综合征 

分 类 号：R256.3[医药卫生—中医内科学]